25 XP   0   0   10

Ceapro
Buy, Hold or Sell?

Let's analyse Ceapro together

PenkeI guess you are interested in Ceapro. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ceapro. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ceapro

I send you an email if I find something interesting about Ceapro.

Quick analysis of Ceapro (30 sec.)










What can you expect buying and holding a share of Ceapro? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.41
Expected worth in 1 year
C$0.67
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
C$0.26
Return On Investment
99.7%

For what price can you sell your share?

Current Price per Share
C$0.26
Expected price per share
C$0.23 - C$0.27
How sure are you?
50%

1. Valuation of Ceapro (5 min.)




Live pricePrice per Share (EOD)

C$0.26

Intrinsic Value Per Share

C$0.26 - C$1.53

Total Value Per Share

C$0.67 - C$1.94

2. Growth of Ceapro (5 min.)




Is Ceapro growing?

Current yearPrevious yearGrowGrow %
How rich?$23.6m$19.8m$3.7m15.8%

How much money is Ceapro making?

Current yearPrevious yearGrowGrow %
Making money$3.2m$2.4m$755.4k23.5%
Net Profit Margin23.3%19.6%--

How much money comes from the company's main activities?

3. Financial Health of Ceapro (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#560 / 1010

Most Revenue
#267 / 1010

Most Profit
#121 / 1010

Most Efficient
#68 / 1010

What can you expect buying and holding a share of Ceapro? (5 min.)

Welcome investor! Ceapro's management wants to use your money to grow the business. In return you get a share of Ceapro.

What can you expect buying and holding a share of Ceapro?

First you should know what it really means to hold a share of Ceapro. And how you can make/lose money.

Speculation

The Price per Share of Ceapro is C$0.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ceapro.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ceapro, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.41. Based on the TTM, the Book Value Change Per Share is C$0.06 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ceapro.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.0415.7%0.0415.7%0.0310.2%0.015.5%0.026.1%
Usd Book Value Change Per Share0.0518.2%0.0518.2%0.0310.0%0.026.9%0.0311.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0518.2%0.0518.2%0.0310.0%0.026.9%0.0311.6%
Usd Price Per Share0.43-0.43-0.45-0.38-0.43-
Price to Earnings Ratio10.54-10.54-16.87--12.48-1.23-
Price-to-Total Gains Ratio9.10-9.10-17.15-13.86-41.49-
Price to Book Ratio1.44-1.44-1.76-1.55-7.22-
Price-to-Total Gains Ratio9.10-9.10-17.15-13.86-41.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.190216
Number of shares5257
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.02
Usd Total Gains Per Share0.050.02
Gains per Quarter (5257 shares)249.3694.58
Gains per Year (5257 shares)997.45378.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109979870378368
20199519840757746
3029922981011351124
4039903978015131502
5049874975018921880
6059855972022702258
7069826969026482636
8079807966030263014
9089778963034053392
10099759960037833770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%7.03.00.070.0%11.016.00.040.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%19.08.00.070.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.026.03.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%19.08.00.070.4%

Fundamentals of Ceapro

About Ceapro

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Fundamental data was last updated by Penke on 2024-04-21 02:03:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ceapro.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ceapro earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • A Net Profit Margin of 23.3% means that $0.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ceapro:

  • The MRQ is 23.3%. The company is making a huge profit. +2
  • The TTM is 23.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.3%TTM23.3%0.0%
TTM23.3%YOY19.6%+3.8%
TTM23.3%5Y8.7%+14.6%
5Y8.7%10Y12.9%-4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.3%-207.2%+230.5%
TTM23.3%-218.5%+241.8%
YOY19.6%-284.8%+304.4%
5Y8.7%-435.1%+443.8%
10Y12.9%-589.3%+602.2%
1.1.2. Return on Assets

Shows how efficient Ceapro is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • 11.7% Return on Assets means that Ceapro generated $0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ceapro:

  • The MRQ is 11.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.7%0.0%
TTM11.7%YOY11.0%+0.6%
TTM11.7%5Y4.7%+6.9%
5Y4.7%10Y8.9%-4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-13.2%+24.9%
TTM11.7%-12.7%+24.4%
YOY11.0%-11.5%+22.5%
5Y4.7%-13.8%+18.5%
10Y8.9%-15.5%+24.4%
1.1.3. Return on Equity

Shows how efficient Ceapro is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • 13.6% Return on Equity means Ceapro generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ceapro:

  • The MRQ is 13.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.6%TTM13.6%0.0%
TTM13.6%YOY12.4%+1.2%
TTM13.6%5Y5.4%+8.2%
5Y5.4%10Y25.0%-19.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6%-16.8%+30.4%
TTM13.6%-16.0%+29.6%
YOY12.4%-14.8%+27.2%
5Y5.4%-19.3%+24.7%
10Y25.0%-20.0%+45.0%

1.2. Operating Efficiency of Ceapro.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ceapro is operating .

  • Measures how much profit Ceapro makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • An Operating Margin of 28.2% means the company generated $0.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ceapro:

  • The MRQ is 28.2%. The company is operating very efficient. +2
  • The TTM is 28.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ28.2%TTM28.2%0.0%
TTM28.2%YOY14.1%+14.2%
TTM28.2%5Y9.8%+18.5%
5Y9.8%10Y15.8%-6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.2%-299.8%+328.0%
TTM28.2%-239.2%+267.4%
YOY14.1%-295.4%+309.5%
5Y9.8%-485.9%+495.7%
10Y15.8%-624.6%+640.4%
1.2.2. Operating Ratio

Measures how efficient Ceapro is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are $0.71 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ceapro:

  • The MRQ is 0.708. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.708. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.7080.000
TTM0.708YOY0.847-0.139
TTM0.7085Y0.868-0.160
5Y0.86810Y0.814+0.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7083.238-2.530
TTM0.7083.313-2.605
YOY0.8473.838-2.991
5Y0.8685.675-4.807
10Y0.8147.612-6.798

1.3. Liquidity of Ceapro.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ceapro is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.80 means the company has $9.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ceapro:

  • The MRQ is 9.800. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.800. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.800TTM9.8000.000
TTM9.800YOY12.064-2.264
TTM9.8005Y7.313+2.487
5Y7.31310Y4.599+2.714
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8003.870+5.930
TTM9.8004.173+5.627
YOY12.0645.332+6.732
5Y7.3136.126+1.187
10Y4.5996.448-1.849
1.3.2. Quick Ratio

Measures if Ceapro is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • A Quick Ratio of 7.95 means the company can pay off $7.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ceapro:

  • The MRQ is 7.947. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.947. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.947TTM7.9470.000
TTM7.947YOY10.204-2.257
TTM7.9475Y6.068+1.879
5Y6.06810Y3.798+2.270
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9473.510+4.437
TTM7.9473.994+3.953
YOY10.2045.357+4.847
5Y6.0686.105-0.037
10Y3.7986.404-2.606

1.4. Solvency of Ceapro.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ceapro assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ceapro to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Ceapro assets are financed with 14.4% credit (debt) and the remaining percentage (100% - 14.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ceapro:

  • The MRQ is 0.144. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.144. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.144TTM0.1440.000
TTM0.144YOY0.109+0.035
TTM0.1445Y0.137+0.007
5Y0.13710Y0.321-0.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1440.339-0.195
TTM0.1440.336-0.192
YOY0.1090.271-0.162
5Y0.1370.368-0.231
10Y0.3210.388-0.067
1.4.2. Debt to Equity Ratio

Measures if Ceapro is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ceapro to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.9% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ceapro:

  • The MRQ is 0.169. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.169. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.169TTM0.1690.000
TTM0.169YOY0.122+0.046
TTM0.1695Y0.161+0.007
5Y0.16110Y2.473-2.312
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1690.390-0.221
TTM0.1690.402-0.233
YOY0.1220.339-0.217
5Y0.1610.428-0.267
10Y2.4730.461+2.012

2. Market Valuation of Ceapro

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ceapro generates.

  • Above 15 is considered overpriced but always compare Ceapro to the Biotechnology industry mean.
  • A PE ratio of 10.54 means the investor is paying $10.54 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ceapro:

  • The EOD is 4.645. Based on the earnings, the company is cheap. +2
  • The MRQ is 10.542. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.542. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.645MRQ10.542-5.896
MRQ10.542TTM10.5420.000
TTM10.542YOY16.866-6.324
TTM10.5425Y-12.480+23.022
5Y-12.48010Y1.232-13.712
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.645-2.296+6.941
MRQ10.542-2.600+13.142
TTM10.542-2.726+13.268
YOY16.866-4.145+21.011
5Y-12.480-6.259-6.221
10Y1.232-6.348+7.580
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ceapro:

  • The EOD is 3.245. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.364. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.364. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.245MRQ7.364-4.119
MRQ7.364TTM7.3640.000
TTM7.364YOY17.112-9.747
TTM7.3645Y12.654-5.289
5Y12.65410Y-158.105+170.759
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.245-2.937+6.182
MRQ7.364-3.326+10.690
TTM7.364-3.553+10.917
YOY17.112-5.605+22.717
5Y12.654-8.385+21.039
10Y-158.105-8.882-149.223
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ceapro is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.44 means the investor is paying $1.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ceapro:

  • The EOD is 0.633. Based on the equity, the company is cheap. +2
  • The MRQ is 1.436. Based on the equity, the company is underpriced. +1
  • The TTM is 1.436. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.633MRQ1.436-0.803
MRQ1.436TTM1.4360.000
TTM1.436YOY1.763-0.327
TTM1.4365Y1.549-0.113
5Y1.54910Y7.225-5.676
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6331.909-1.276
MRQ1.4362.114-0.678
TTM1.4362.096-0.660
YOY1.7632.884-1.121
5Y1.5493.554-2.005
10Y7.2253.938+3.287
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ceapro compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0650.0650%0.036+82%0.025+164%0.041+58%
Book Value Per Share--0.4110.4110%0.346+19%0.330+25%0.235+75%
Current Ratio--9.8009.8000%12.064-19%7.313+34%4.599+113%
Debt To Asset Ratio--0.1440.1440%0.109+32%0.137+5%0.321-55%
Debt To Equity Ratio--0.1690.1690%0.122+38%0.161+5%2.473-93%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0560.0560%0.036+55%0.019+187%0.022+158%
Free Cash Flow Per Share--0.0800.0800%0.036+125%0.026+206%0.007+1091%
Free Cash Flow To Equity Per Share--0.0770.0770%0.032+144%0.020+289%0.021+268%
Gross Profit Margin--0.9930.9930%0.986+1%1.202-17%1.055-6%
Intrinsic Value_10Y_max--1.526--------
Intrinsic Value_10Y_min--0.257--------
Intrinsic Value_1Y_max--0.076--------
Intrinsic Value_1Y_min--0.012--------
Intrinsic Value_3Y_max--0.287--------
Intrinsic Value_3Y_min--0.047--------
Intrinsic Value_5Y_max--0.569--------
Intrinsic Value_5Y_min--0.096--------
Market Cap20356232.000-128%46363428.97046363428.9700%47940330.660-3%40234795.526+15%46502206.1630%
Net Profit Margin--0.2330.2330%0.196+19%0.087+167%0.129+80%
Operating Margin--0.2820.2820%0.141+101%0.098+189%0.158+79%
Operating Ratio--0.7080.7080%0.847-16%0.868-18%0.814-13%
Pb Ratio0.633-127%1.4361.4360%1.763-19%1.549-7%7.225-80%
Pe Ratio4.645-127%10.54210.5420%16.866-37%-12.480+218%1.232+756%
Price Per Share0.260-127%0.5900.5900%0.610-3%0.513+15%0.594-1%
Price To Free Cash Flow Ratio3.245-127%7.3647.3640%17.112-57%12.654-42%-158.105+2247%
Price To Total Gains Ratio4.010-127%9.1009.1000%17.154-47%13.857-34%41.493-78%
Quick Ratio--7.9477.9470%10.204-22%6.068+31%3.798+109%
Return On Assets--0.1170.1170%0.110+6%0.047+147%0.089+30%
Return On Equity--0.1360.1360%0.124+10%0.054+150%0.250-45%
Total Gains Per Share--0.0650.0650%0.036+82%0.025+164%0.041+58%
Usd Book Value--23622697.51223622697.5120%19897380.070+19%18922586.134+25%13496631.643+75%
Usd Book Value Change Per Share--0.0470.0470%0.026+82%0.018+164%0.030+58%
Usd Book Value Per Share--0.3010.3010%0.253+19%0.241+25%0.172+75%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0410.0410%0.026+55%0.014+187%0.016+158%
Usd Free Cash Flow--4605847.7914605847.7910%2049633.733+125%1504992.211+206%387728.539+1088%
Usd Free Cash Flow Per Share--0.0590.0590%0.026+125%0.019+206%0.005+1091%
Usd Free Cash Flow To Equity Per Share--0.0570.0570%0.023+144%0.015+289%0.015+268%
Usd Market Cap14892619.331-128%33919484.63433919484.6340%35073145.911-3%29435776.407+15%34021014.0290%
Usd Price Per Share0.190-127%0.4320.4320%0.446-3%0.375+15%0.434-1%
Usd Profit--3217648.4973217648.4970%2462166.878+31%1195652.124+169%1282118.904+151%
Usd Revenue--13783056.48113783056.4810%12580102.696+10%11066019.185+25%9387191.571+47%
Usd Total Gains Per Share--0.0470.0470%0.026+82%0.018+164%0.030+58%
 EOD+4 -4MRQTTM+0 -0YOY+26 -85Y+28 -610Y+26 -8

3.2. Fundamental Score

Let's check the fundamental score of Ceapro based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.645
Price to Book Ratio (EOD)Between0-10.633
Net Profit Margin (MRQ)Greater than00.233
Operating Margin (MRQ)Greater than00.282
Quick Ratio (MRQ)Greater than17.947
Current Ratio (MRQ)Greater than19.800
Debt to Asset Ratio (MRQ)Less than10.144
Debt to Equity Ratio (MRQ)Less than10.169
Return on Equity (MRQ)Greater than0.150.136
Return on Assets (MRQ)Greater than0.050.117
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Ceapro based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.119
Ma 20Greater thanMa 500.246
Ma 50Greater thanMa 1000.231
Ma 100Greater thanMa 2000.213
OpenGreater thanClose0.245
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Tax Provision  -606602-30-3-220-2241,6031,379



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets37,734
Total Liabilities5,445
Total Stockholder Equity32,289
 As reported
Total Liabilities 5,445
Total Stockholder Equity+ 32,289
Total Assets = 37,734

Assets

Total Assets37,734
Total Current Assets20,588
Long-term Assets17,146
Total Current Assets
Cash And Cash Equivalents 13,811
Net Receivables 2,885
Inventory 3,757
Other Current Assets 135
Total Current Assets  (as reported)20,588
Total Current Assets  (calculated)20,588
+/-0
Long-term Assets
Property Plant Equipment 16,202
Intangible Assets 13
Long-term Assets Other 932
Long-term Assets  (as reported)17,146
Long-term Assets  (calculated)17,146
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,101
Long-term Liabilities3,345
Total Stockholder Equity32,289
Total Current Liabilities
Short-term Debt 370
Accounts payable 1,730
Other Current Liabilities 1,730
Total Current Liabilities  (as reported)2,101
Total Current Liabilities  (calculated)3,831
+/- 1,730
Long-term Liabilities
Capital Lease Obligations 2,619
Long-term Liabilities  (as reported)3,345
Long-term Liabilities  (calculated)2,619
+/- 726
Total Stockholder Equity
Common Stock16,695
Retained Earnings 10,880
Other Stockholders Equity 4,714
Total Stockholder Equity (as reported)32,289
Total Stockholder Equity (calculated)32,289
+/-0
Other
Capital Stock16,695
Cash and Short Term Investments 13,811
Common Stock Shares Outstanding 78,582
Current Deferred Revenue-1,730
Liabilities and Stockholders Equity 37,734
Net Debt -11,192
Net Invested Capital 32,289
Net Working Capital 18,487
Property Plant and Equipment Gross 27,836
Short Long Term Debt Total 2,619



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
> Total Assets 
18,600
13,100
500
300
294
373
645
1,255
1,718
2,419
2,063
4,588
3,287
2,771
2,820
4,171
3,886
5,097
7,683
15,703
26,392
27,808
25,325
27,269
29,224
30,528
37,734
37,73430,52829,22427,26925,32527,80826,39215,7037,6835,0973,8864,1712,8202,7713,2874,5882,0632,4191,7181,25564537329430050013,10018,600
   > Total Current Assets 
3,300
300
200
200
181
273
372
908
933
1,739
1,284
2,277
1,058
846
1,107
1,864
2,378
3,149
1,648
3,846
11,394
8,997
6,135
6,411
9,050
11,727
20,588
20,58811,7279,0506,4116,1358,99711,3943,8461,6483,1492,3781,8641,1078461,0582,2771,2841,7399339083722731812002003003,300
       Cash And Cash Equivalents 
1,000
0
0
0
38
51
25
248
96
438
311
1,282
17
116
187
592
273
1,953
273
1,681
9,150
6,174
1,844
1,857
5,369
7,781
13,811
13,8117,7815,3691,8571,8446,1749,1501,6812731,953273592187116171,282311438962482551380001,000
       Net Receivables 
1,200
200
100
100
70
80
275
514
375
982
634
708
552
151
570
465
453
530
634
663
688
1,460
3,062
3,706
2,122
2,139
2,885
2,8852,1392,1223,7063,0621,46068866363453045346557015155270863498237551427580701001002001,200
       Inventory 
1,100
0
0
0
64
87
57
116
345
228
160
157
407
517
279
691
790
324
679
1,242
1,183
1,085
711
669
1,210
1,645
3,757
3,7571,6451,2106697111,0851,1831,2426793247906912795174071571602283451165787640001,100
   > Long-term Assets 
15,300
12,800
300
100
114
101
274
347
784
680
778
2,310
2,230
1,925
1,713
2,307
1,508
1,948
6,035
11,857
14,998
18,811
19,189
20,858
20,174
18,801
17,146
17,14618,80120,17420,85819,18918,81114,99811,8576,0351,9481,5082,3071,7131,9252,2302,31077868078434727410111410030012,80015,300
       Property Plant Equipment 
8,300
200
100
100
114
101
274
347
784
680
611
2,260
2,200
1,898
1,689
1,521
1,434
1,853
5,962
9,869
14,325
17,380
17,948
19,764
18,591
17,500
16,202
16,20217,50018,59119,76417,94817,38014,3259,8695,9621,8531,4341,5211,6891,8982,2002,2606116807843472741011141001002008,300
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
219
0
0
0
0
0
00000219000000000000000000000
       Intangible Assets 
6,000
6,000
200
0
0
0
0
0
0
0
0
0
30
27
24
36
74
66
36
33
30
517
24
21
19
16
13
13161921245173033366674362427300000000002006,0006,000
       Long-term Assets Other 
1,000
6,600
0
0
0
0
0
0
0
0
168
50
0
0
0
750
0
29
37
93
91
696
696
693
690
846
932
93284669069369669691933729075000050168000000006,6001,000
> Total Liabilities 
10,600
3,700
1,600
2,200
2,685
1,511
1,298
873
1,604
1,958
1,759
3,034
5,219
4,143
3,372
3,653
3,872
4,853
5,591
7,827
3,991
5,264
2,110
4,957
4,914
3,331
5,445
5,4453,3314,9144,9572,1105,2643,9917,8275,5914,8533,8723,6533,3724,1435,2193,0341,7591,9581,6048731,2981,5112,6852,2001,6003,70010,600
   > Total Current Liabilities 
5,500
3,400
1,500
2,100
2,212
624
622
622
1,066
736
644
852
3,448
2,119
1,927
1,510
2,566
2,213
2,965
5,203
2,534
4,067
1,360
1,741
1,391
972
2,101
2,1019721,3911,7411,3604,0672,5345,2032,9652,2132,5661,5101,9272,1193,4488526447361,0666226226242,2122,1001,5003,4005,500
       Short-term Debt 
3,600
1,100
300
500
326
82
169
86
168
115
73
113
132
139
614
154
169
573
841
1,930
1,075
934
410
450
323
290
370
3702903234504109341,0751,9308415731691546141391321137311516886169823265003001,1003,600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,192
841
1,057
1,075
934
410
185
72
0
0
00721854109341,0751,0578413,19200000000000000000
       Accounts payable 
1,500
2,300
1,300
1,600
1,752
522
454
536
713
285
336
494
1,606
1,781
1,240
624
578
994
1,791
2,006
969
965
950
1,291
1,068
682
1,730
1,7306821,0681,2919509659692,0061,7919945786241,2401,7811,6064943362857135364545221,7521,6001,3002,3001,500
       Other Current Liabilities 
400
0
-100
0
134
20
169
86
104
107
130
138
1,653
139
13
160
120
284
170
95
490
3,133
950
1,291
1,068
682
1,730
1,7306821,0681,2919503,13349095170284120160131391,65313813010710486169201340-1000400
   > Long-term Liabilities 
5,100
300
100
100
473
887
676
251
538
1,221
1,115
2,182
1,770
2,025
1,445
2,143
1,306
2,640
2,626
2,624
1,457
1,197
750
3,216
3,523
2,359
3,345
3,3452,3593,5233,2167501,1971,4572,6242,6262,6401,3062,1431,4452,0251,7702,1821,1151,2215382516768874731001003005,100
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
0
112
0
605
524
379
874
0
0
008743795246050112012700000000000000000
> Total Stockholder Equity
8,000
9,400
-1,100
-1,900
-2,391
-1,137
-653
382
114
461
304
1,554
-1,931
-1,373
-552
518
14
244
2,092
7,877
22,401
22,544
23,215
22,312
24,310
27,197
32,289
32,28927,19724,31022,31223,21522,54422,4017,8772,09224414518-552-1,373-1,9311,554304461114382-653-1,137-2,391-1,900-1,1009,4008,000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,316
6,316
6,566
6,800
14,859
15,566
16,321
16,402
16,511
16,557
16,695
16,69516,55716,51116,40216,32115,56614,8596,8006,5666,3166,3160000000000000000
   Retained Earnings 
-10,900
-30,700
-44,900
-45,800
-46,720
-47,099
-2,048
-1,606
-2,003
-2,060
-2,333
-3,722
-7,322
-7,391
-6,890
-6,196
-6,734
-6,558
-4,964
-59
3,667
2,709
2,393
1,260
3,117
5,959
10,880
10,8805,9593,1171,2602,3932,7093,667-59-4,964-6,558-6,734-6,196-6,890-7,391-7,322-3,722-2,333-2,060-2,003-1,606-2,048-47,099-46,720-45,800-44,900-30,700-10,900
   Capital Surplus 000000000000000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
18,900
40,100
43,800
43,900
44,329
45,962
1,395
1,988
1,995
2,522
2,637
5,276
5,390
6,018
6,338
6,713
432
6,820
7,073
7,936
18,734
19,835
4,501
4,650
4,682
4,681
4,714
4,7144,6814,6824,6504,50119,83518,7347,9367,0736,8204326,7136,3386,0185,3905,2762,6372,5221,9951,9881,39545,96244,32943,90043,80040,10018,900



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,305
Cost of Revenue-6,345
Gross Profit4,9604,960
 
Operating Income (+$)
Gross Profit4,960
Operating Expense-15,160
Operating Income-3,855-10,200
 
Operating Expense (+$)
Research Development2,660
Selling General Administrative6,155
Selling And Marketing Expenses-
Operating Expense15,1608,815
 
Net Interest Income (+$)
Interest Income-
Interest Expense-131
Other Finance Cost-55
Net Interest Income-186
 
Pretax Income (+$)
Operating Income-3,855
Net Interest Income-186
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,569-4,327
EBIT - interestExpense = -131
-2,810
-2,679
Interest Expense131
Earnings Before Interest and Taxes (EBIT)--3,438
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-3,569
Tax Provision--759
Net Income From Continuing Ops-2,810-2,810
Net Income-2,810
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net472186
 

Technical Analysis of Ceapro
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ceapro. The general trend of Ceapro is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ceapro's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ceapro.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.26 < 0.27 < 0.27.

The bearish price targets are: 0.24 > 0.23 > 0.23.

Tweet this
Ceapro Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ceapro. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ceapro Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ceapro. The current macd is 0.00415969.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ceapro price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ceapro. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ceapro price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ceapro Daily Moving Average Convergence/Divergence (MACD) ChartCeapro Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ceapro. The current adx is 15.77.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ceapro shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Ceapro Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ceapro. The current sar is 0.23.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ceapro Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ceapro. The current rsi is 62.12. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Ceapro Daily Relative Strength Index (RSI) ChartCeapro Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ceapro. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ceapro price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ceapro Daily Stochastic Oscillator ChartCeapro Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ceapro. The current cci is 96.36.

Ceapro Daily Commodity Channel Index (CCI) ChartCeapro Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ceapro. The current cmo is 33.29.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ceapro Daily Chande Momentum Oscillator (CMO) ChartCeapro Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ceapro. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Ceapro Daily Williams %R ChartCeapro Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ceapro.

Ceapro Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ceapro. The current atr is 0.00750048.

Ceapro Daily Average True Range (ATR) ChartCeapro Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ceapro. The current obv is -2,807,500.

Ceapro Daily On-Balance Volume (OBV) ChartCeapro Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ceapro. The current mfi is 69.04.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ceapro Daily Money Flow Index (MFI) ChartCeapro Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ceapro.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Ceapro Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ceapro based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.119
Ma 20Greater thanMa 500.246
Ma 50Greater thanMa 1000.231
Ma 100Greater thanMa 2000.213
OpenGreater thanClose0.245
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ceapro with someone you think should read this too:
  • Are you bullish or bearish on Ceapro? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ceapro? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ceapro

I send you an email if I find something interesting about Ceapro.


Comments

How you think about this?

Leave a comment

Stay informed about Ceapro.

Receive notifications about Ceapro in your mailbox!